stonks4u
Sign up free
MKKGY logo

MKKGY Merck KGaA

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$31.58
-0.70 (-2.17%)

Merck KGaA is a leading German science and technology enterprise. Its business operations are strategically organized into three core divisions: Life Science, Healthcare, and Electronics. The Life Science segment provides an extensive portfolio of tools, chemicals, and equipment essential for academic research laboratories, biotech firms, pharmaceutical manufacturers, and the broader industrial se…

Market Cap: $68.65Bwww.merckgroup.com

Price (90d)

$33.38
$25.65$28.38$31.10$33.83
Apr 30Aug 7

Signal Score (90d)

120
120
Aug 8Aug 8

Quote

Day Range
$31.46 – $31.73
52-Week Range
$23.73 – $34.19
Volume
$4.2K
Market Cap
$68.65B
50-Day Avg
$32.17
200-Day Avg
$28.80
Prev Close
$32.28
Open
$31.73

Valuation & Ratios

P/E Ratio
21.26
EPS
$1.15
P/B Ratio
1.86
P/S Ratio
2.62
Debt/Equity
0.42
Current Ratio
1.46
Dividend Yield
+1.9%
Gross Margin
+56.4%

Returns & Efficiency

Return on Equity
+8.8%
Return on Assets
+4.8%
FCF Yield
+4.3%
EV/EBITDA
10.98

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$20.27B$2.51B$1.15
2024$21.16B$2.78B$1.28
2023$20.99B$2.82B$1.30
2022$22.23B$3.33B$1.53
2021$19.69B$3.06B$1.41

Social Signal Score

70
5d
—
30d
70
1 mentions
+5.6%
60d
70
1 mentions
+8.7%
90d
70
1 mentions
+22.9%
news: 1

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $0.47 per share

5of 7 quarters beat consensus

Typical surprise +14.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.26 vs $0.47miss
  • Wed, May 13$0.59 vs $0.45beat
  • Thu, Mar 5$0.28 vs $0.47miss
  • Thu, Nov 13$0.81 vs $0.54beat
  • Thu, Aug 7$0.57 vs $0.51beat
  • Thu, May 15$0.59 vs $0.50beat

Estimates and results for MKKGY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from MKKGY's reported EPS growth of -5.0% a year over 4 years.

EPS in 5 years
$0.89
Implied price
$18.72
Return from $31.58
-9.9% a year

To earn 15.0% a year on these assumptions you'd need to buy at $9.31 — -70.5% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1518212427
-15.0%-24.7%-21.9%-19.4%-17.2%-15.3%
-10.0%-20.2%-17.3%-14.7%-12.4%-10.3%
-5.0%-15.8%-12.7%-9.9%-7.5%-5.3%
0.0%-11.4%-8.1%-5.2%-2.6%-0.3%
5.0%-6.9%-3.5%-0.4%2.3%4.7%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·7d ago·Positive

    Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript

    View source ↗